Hint mode is switched on Switch off

Kodiak Sciences, ordinary share
KOD, US50015M1099

Add a stock to WL
Choose all Reset all
Kodiak Sciences, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak ...
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat ophthalmic diseases. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Kodiak Sciences Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KOD
  • Placement
    04.10.2018
  • Lock up period
    180
  • Number of papers
    9,000,000
  • Volume of raised funds
    90 mln USD
  • Placement share
    24.61%
  • Final placement price
    10 USD
  • Price change since placement date
    209.4%
  • By capitalization
    365.73 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KOD
  • Placement
    04.12.2019
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    276 mln USD
  • Placement share
    13.95%
  • Final placement price
    46 USD
  • Price change since placement date
    -32.74%
  • By capitalization
    1,978.41 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KOD
  • Placement
    18.11.2020
  • Lock up period
    180
  • Number of papers
    5,193,237
  • Volume of raised funds
    560.87 mln USD
  • Placement share
    10.4%
  • Final placement price
    108 USD
  • Price change since placement date
    -71.35%
  • By capitalization
    5,395.01 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    KOD
  • Placement
    15.12.2025
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    142.86 mln USD
  • Placement share
    10.17%
  • Final placement price
    23.81 USD
  • Price change since placement date
    29.95%
  • By capitalization
    1,404.76 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

16/12/2025 Kodiak Sciences: Other Events, Financial Statements And Exhibits
14/08/2025 JPMorgan Upgrades Kodiak Sciences To Neutral, Sees Catalyst-Heavy Period Ahead
02/06/2025 Kodiak Sciences: Submission Of Matters To A Vote Of Security Holders
27/03/2025 Kodiak Sciences: Results Of Operations And Financial Condition, Financial Statements And Exhibits
15/05/2024 Kodiak Sciences: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.